Back to mobile site

Pfizer (PFE) Earnings Growth 'Underappreciated' - Cantor Fitzgerald

July 28, 2022 1:32 PM EDT Send to a Friend
Pfizer (NYSE: PFE) topped estimates when it reported earnings for the second quarter premarket Thursday. The drugmaker reported a profit ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login